TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 66 filers reported holding TAYSHA GENE THERAPIES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $462,357 | +439.3% | 161,100 | +232.6% | 0.00% | +200.0% |
| Q4 2023 | $85,728 | -5.9% | 48,434 | +20.2% | 0.00% | 0.0% |
| Q4 2022 | $91,080 | -58.6% | 40,301 | +19.6% | 0.00% | -50.0% |
| Q1 2022 | $220,000 | -3.9% | 33,694 | +71.6% | 0.00% | 0.0% |
| Q4 2021 | $229,000 | +94.1% | 19,635 | +340.9% | 0.00% | 0.0% |
| Q4 2020 | $118,000 | – | 4,453 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 2,000,000 | $53,080,000 | 57.48% |
| Octagon Capital Advisors LP | 320,440 | $8,504,000 | 2.95% |
| Alphabet Inc. | 640,882 | $17,009,000 | 0.82% |
| Casdin Capital, LLC | 820,440 | $21,774,000 | 0.64% |
| Artal Group S.A. | 1,040,882 | $27,625,000 | 0.59% |
| VR Adviser, LLC | 107,982 | $2,866,000 | 0.42% |
| Avidity Partners Management LP | 392,000 | $10,404,000 | 0.34% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 500,000 | $13,270,000 | 0.28% |
| Perceptive Advisors | 470,440 | $12,485,000 | 0.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 250,000 | $6,635,000 | 0.13% |